These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31017753)

  • 1. Tretinoin Formulation: From Microsponges to Polymeric Emulsion.
    Kircik LH
    J Drugs Dermatol; 2019 Apr; 18(4):s147. PubMed ID: 31017753
    [No Abstract]   [Full Text] [Related]  

  • 2. Polymeric Emulsion Technology Applied to Tretinoin.
    Kircik LH; Draelos ZD; Berson DS
    J Drugs Dermatol; 2019 Apr; 18(4):s148-154. PubMed ID: 31017754
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel Polymeric Lotion Formulation of Once-Daily Tazarotene (0.045%) for Moderate-to-Severe Acne: Pooled Phase 3 Analysis.
    Tanghetti EA; Werschler WP; Lain E; Guenin E; Harris S; Loncaric A; Pillai R
    J Drugs Dermatol; 2020 Mar; 19(3):272-279. PubMed ID: 32549090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, vehicle-controlled, multicenter comparison of two 0.025% tretinoin creams in patients with acne vulgaris.
    Lucky AW; Cullen SI; Funicella T; Jarratt MT; Jones T; Reddick ME
    J Am Acad Dermatol; 1998 Apr; 38(4):S24-30. PubMed ID: 9555823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Once-Daily Tretinoin 0.05% Lotion on Quality of Life in Patients with Moderate-to-Severe Acne Vulgaris.
    Tyring SK; Kircik L; Pariser DM; Woolery-Lloyd HC; Harper JC; Bhatt V; Pillai R; Guenin E
    Am J Clin Dermatol; 2020 Dec; 21(6):891-899. PubMed ID: 32886337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved photostability and reduced skin permeation of tretinoin: development of a semisolid nanomedicine.
    Ourique AF; Melero A; de Bona da Silva C; Schaefer UF; Pohlmann AR; Guterres SS; Lehr CM; Kostka KH; Beck RC
    Eur J Pharm Biopharm; 2011 Sep; 79(1):95-101. PubMed ID: 21402157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating tretinoin formulations in the treatment of acne.
    Kircik LH
    J Drugs Dermatol; 2014 Apr; 13(4):466-70. PubMed ID: 24719067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous absorption and antibacterial activities of lipid nanocarriers loaded with dual drugs for acne treatment.
    Lin CH; Fang YP; Al-Suwayeh SA; Yang SY; Fang JY
    Biol Pharm Bull; 2013; 36(2):276-86. PubMed ID: 23370356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Tretinoin 0.05% Lotion for the Once-daily Treatment of Moderate-to-Severe Acne Vulgaris in an Adult and Adolescent Female Population.
    Kircik LH; Baldwin H; Lain E; Guenin E; Harris S; Bhatt V
    J Drugs Dermatol; 2019 Feb; 18(2):178-188. PubMed ID: 30811141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Tretinoin 0.05% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in a Hispanic Population.
    Cook-Bolden FE; Weinkle SH; Guenin E; Bhatt V
    J Drugs Dermatol; 2019 Jan; 18(1):32-38. PubMed ID: 30681791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adapalene 0.1% gel for the treatment of acne vulgaris: its superiority compared to tretinoin 0.025% cream in skin tolerance and patient preference.
    Dunlap FE; Mills OH; Tuley MR; Baker MD; Plott RT
    Br J Dermatol; 1998 Oct; 139 Suppl 52():17-22. PubMed ID: 9990416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical treatment of acne vulgaris: retinoids and cutaneous irritation.
    Leyden JJ
    J Am Acad Dermatol; 1998 Apr; 38(4):S1-4. PubMed ID: 9555819
    [No Abstract]   [Full Text] [Related]  

  • 13. Topical tretinoin and fetal malformations.
    Colley SM; Walpole I; Fabian VA; Kakulas BA
    Med J Aust; 1998 May; 168(9):467. PubMed ID: 9612461
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative efficacy and safety of two 0.025% tretinoin gels: results from a multicenter double-blind, parallel study.
    Lucky AW; Cullen SI; Jarratt MT; Quigley JW
    J Am Acad Dermatol; 1998 Apr; 38(4):S17-23. PubMed ID: 9555822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Split-face clinical and bio-instrumental comparison of 0.1% adapalene and 0.05% tretinoin in facial acne.
    Piérard-Franchimont C; Henry F; Fraiture AL; Fumal I; Piérard GE
    Dermatology; 1999; 198(2):218-22. PubMed ID: 10325486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced skin irritation with tretinoin containing polyolprepolymer-2, a new topical tretinoin delivery system: a summary of preclinical and clinical investigations.
    Quigley JW; Bucks DA
    J Am Acad Dermatol; 1998 Apr; 38(4):S5-10. PubMed ID: 9555820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical tretinoin or adapalene in acne vulgaris: an overview.
    Jain S
    J Dermatolog Treat; 2004 Jul; 15(4):200-7. PubMed ID: 15764031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of Velac, a new tretinoin and clindamycin phosphate gel in acne vulgaris.
    Cambazard F
    J Eur Acad Dermatol Venereol; 1998 Sep; 11 Suppl 1():S20-7; discussion S28-9. PubMed ID: 9891905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tretinoin microsphere gel pump 0.04% versus tazarotene cream 0.05% in the treatment of mild-to-moderate facial acne vulgaris.
    Kircik LH
    J Drugs Dermatol; 2009 Jul; 8(7):650-4. PubMed ID: 19588641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation, In-Vitro and Ex-Vivo Evaluation of Tretinoin Loaded Cubosomal Gel for the Treatment of Acne.
    Sureka S; Gupta G; Agarwal M; Mishra A; K Singh S; P Singh R; Sah SK; de Jesus A Pinto T; Dua K
    Recent Pat Drug Deliv Formul; 2018; 12(2):121-129. PubMed ID: 29437029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.